Day One Biopharmaceuticals Ratios (2022-2025) | DAWN

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -1,353.09%37.28%-202.96%-116.94%-89.37%-49.48%
EBIT Margin -1,401.45%31.61%-223.68%-133.50%-103.14%-60.94%
EBITDA Margin -1,401.45%31.61%-223.68%-133.50%-103.14%-60.94%
Operating Margin -1,401.45%31.61%-223.68%-133.50%-103.14%-60.94%
Net Margin -1,372.03%38.22%-225.02%-116.94%-89.37%-49.48%
FCF Margin -1,271.11%111.99%-168.65%-198.29%-68.20%-14.59%
Efficiency
Inventory Average 1.44M3.03M3.44M5.05M6.80M
Assets Average 335.91M392.95M365.46M336.31M387.16M432.47M395.11M351.35M363.54M500.62M591.80M558.57M526.70M516.41M
Equity Average 325.12M376.85M347.56M316.23M363.23M407.84M368.08M321.67M301.77M431.10M529.11M491.13M470.17M455.85M
Invested Capital 259.60M390.63M363.08M332.04M300.42M426.05M389.63M346.54M296.81M306.73M555.46M502.75M479.51M460.83M450.87M
Asset Utilization Ratio 0.020.200.220.290.360.26
Leverage & Solvency
Equity Ratio 0.970.970.950.950.930.950.940.920.910.770.920.860.900.890.88
Valuation
Enterprise Value -262.73M-388.88M-374.34M-342.27M-318.18M-442.88M-405.54M-366.35M-317.94M-361.87M-558.38M-531.72M-473.02M-453.10M-451.58M
Return Ratios
Return on Sales -13.72%0.38%-2.25%-1.17%-0.89%-0.49%
Return on Capital Employed -0.71%-1.08%-0.46%-0.42%-0.38%-0.24%-0.36%
Return on Invested Capital -0.97%-0.49%-0.43%-0.41%-0.25%-0.38%
Return on Assets -0.12%-0.21%-0.37%-0.59%-0.76%-0.39%-0.35%-0.32%-0.18%-0.29%
Return on Equity -0.13%-0.23%-0.40%-0.65%-0.91%-0.45%-0.39%-0.36%-0.20%-0.33%